|
|
Value and Need for Pharmaceutical Promotion Disputed
Robert L. Deamer, PharmD, BCPS
Arch Fam Med. 1994;3(12):1033.
References Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
1. Wind Y. Pharmaceutical advertising: a business school perspective. Arch Fam Med. 1994;3:321-323.
FREE FULL TEXT
2. Levy R. The role and value of pharmaceutical marketing. Arch Fam Med. 1994;3:327-332.
FREE FULL TEXT
3. Avorn J, Chen M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med. 1982;73:4-8.
PUBMED
4. Wilkes MS, Doblin BH, Shapiro MF. Pharmaceutical advertisements in leading medical journals: experts' assessments. Ann Intern Med. 1992;116:912-919.
FREE FULL TEXT
5. Lurie N, Rich EC, Simpson DE, et al. Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff. J Gen Intern Med. 1990;5:240-243.
PUBMED
6. Schwartz TB. Drug company marketing in the groves of academe. West J Med. 1992;156:660-661.
PUBMED
7. Girard DE. The relationship between physicians in training and pharmaceutical companies: a time for guidelines? Arch Intern Med. 1992;152:920-921.
FREE FULL TEXT
8. Brotzman GL, Mark DH. Policy recommendations for pharmaceutical representative-resident interactions. Fam Med. 1992;24:431-432.
PUBMED
9. Randall T. Kennedy hearings say no more free lunch—or much else—from drug firms. JAMA. 1991;265:440-441.
FREE FULL TEXT
10. Felicetta JV. Why aren't we using more niacin? Arch Fam Med. 1994;3:324-326.
FREE FULL TEXT
|